AQSTCIK 1398733

Aquestive Therapeutics, Inc.

EDGAR filings

Customers

1 disclosed

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Latest period

Mar 31, 2026

10-Q filed 2026-05-13

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Customers 1

Companies AQST discloses as major customers, as a share of AQST revenue. 1 active, 0 lapsed.

Company	% of AQST revenue	Est. revenue	Period	Trend	Status	Source
Assertio Holdings, Inc. Assertio Holdings, Inc.	Named	—	3M 2026-03-31	—	Active	10-Q 2026-05-13
The Company also entered into a long-term supply agreement with Assertio for Sympazan pursuant to which the Company is the exclusive sole worldwide manufacturer and supplier of the product and will receive manufacturing fees from Assertio for the product through the expiration of such supply agreement. 10-Q filed 2026-05-13 Period 3M 2026-01-01 to 2026-03-31Accession 0001398733-26-000030

Alerts are coming

Get an email when AQST's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.